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Abstract
Recombinant human bone morphogenetic protein-2 (rhBMP-2) is well-known osteoin-
ductive growth factors that can be used along with various carriers. Demineralized den-
tin matrix (DDM) that has osteoinductive and osteoconductive capacities was developed 
as potential candidate for rhBMP-2 carrier that has its endogenous growth factors and 
fulfils the requirements such as controlled release kinetics, biocompatibility, biodegrad-
abilities and bone forming capacity. DDM loaded with rhBMP-2 (DDM/rhBMP-2) have 
been subjected to in vitro, in vivo studies for the purpose of proving the clinical safety 
and efficacy. Recently the clinical trials and outcomes of DDM/rhBMP-2 have also proved 
this composite to be safe and efficient in terms of enhanced bone formation, remodeling 
capacity and reduced concentration of rhBMP-2 in implant dentistry in Korea. This chap-
ter will introduce the clinical application of DDM/rhBMP-2 in implant dentistry based on 
the related experimental and clinical researches.
Keywords: demineralized dentin matrix (DDM), recombinant human bone 
morphogenetic protein-2 (rhBMP-2), DDM loaded with rhBMP-2 (DDM/rhBMP-2), 
bone graft, bone regeneration
1. Introduction
Since the first report of clinical application of DDM (AutoBT® Korea Tooth Bank, Seoul, 
Korea) that were developed by Korea Tooth Bank in 2010, many experimental and clinical 
studies have been subjected to improve the biocompatibility, bone forming capacity and to 
expand clinical applications.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
DDM is fabricated from the tooth that is traditionally discarded after extraction as medi-
cal waste product. Based on the historical work of Dr. Urist since 1965 [1], DDM itself can 
be defined as acid insoluble, microporous, type I collagenous scaffold that has several non-
collagenous growth factors such as BMPs, PDGF and FGF2 in addition to a mineral phase 
[2–4]. DDM is mainly processed by dehydration, defatting, and partial demineralization. 
Demineralization with 0.6 N HCl results in the elimination of the major part of the mineral 
phase and immunogenic components, while retaining a very low fraction of minerals (5–10 
wt.%), the majority of Type I collagen, and non-collagenous proteins (NCPs), providing an 
osteoconductive and osteoinductive scaffold [5, 6].
We developed two types of DDM (AutoBT®): one is powder, the other is block. The clinical 
efficacy and safety of DDM powder and block have been approved as new health tech-
nology assessment (nHTA) in Korea 2015 based on the several experimental and clinical 
evidences [7–11].
DDM powder, which is proved to be osteoinductive and osteoconductive, is 300–800μm size 
with enlarged dentinal tubules and loosened collagen matrix that serve as channels for releas-
ing essential growth factors from the dentin matrix. The indications of powder are socket pres-
ervation, alveolar bone augmentation, guided bone regeneration and sinus augmentation [12].
DDM block, which is osteoconductive and osteoinductive, is root form shaped and has sev-
eral 200–300 μm-sized macropores from surface to pulp chamber and canal to provide a space 
for vascular invasion from the host tissues when implanted in the alveolar bone. The indica-
tion of block are socket preservation, alveolar wall repair and replacement of conventional 
membranes [11].
The rhBMP-2 was well known cytokines that has great potential of stimulation, proliferation, 
and differentiation of stem cells into osteoblastic cells to deposit newly formed osteoid. It has 
been shown that rhBMP-2 requires suitable carrier to achieve clinical efficacy. Suitable carri-
ers should meet some requirements such as adequate porosity to allow cell and blood vessel 
infiltration, appropriate mechanical stability against compression and tension, biocompat-
ibility, biodegradability, amenability to sterilization, adhesiveness to adjacent bone, affinity 
for BMPs, and should provide retention of the protein for a sufficient period of time to affect 
the repair [13].
Type I collagen (absorbable collagen sponge, ACS) is the most preferred and commonly used 
BMP carrier. In 2007, the FDA granted approval of rhBMP-2/ACS (INFUSE Bone Graft®, 
Medtronics, Memphis, TN) as an alternative to autogenous bone grafts for sinus augmenta-
tions, and for localized alveolar ridge augmentation of defects associated with extraction 
sockets. Dose dependent clinical studies have determined 1.5mg/cc as a safe and predictable 
dose for bone formation. However, the only approved carrier for rhBMP-2 by the US FDA 
at this time has many drawbacks such as poor mechanical properties, squeezing tendency 
of rhBMP-2 resulting in burst release and overdose complication, and less osteoconductivi-
ties. So that ideal rhBMP-2 carrier has not been established yet in field of clinical implant 
dentistry [14–16].
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DDM has been considered as one of the potential candidate of the rhBMP-2 carrier in perspec-
tives of the main role that is to retain the factor at the site for a prolonged period of time [17]. 
Regarding to DDM as rhBMP-2 carrier, Ike et al. reported that exogenous rhBMP-2 adsorbed 
into pulverized root partially demineralized dentin matrix (PDM) proved to be as osteoinduc-
tive as autogenous bone graft [18]. Murata et al. also showed that human DDM particles are 
osteoinductive, insoluble collagenous matrices, and DDMs might be effective as an rhBMP-2 
carrier for bone engineering [19].
Based on the previous report of Ike and Murata, Kim et al. [20] and Um et al. [21] have reported 
and confirmed in vivo and in vitro studies that support the observations of efficacy of DDM as 
rhBMP-2 carrier. With regard to clinical applications, Kim reported the first successful use of 
DDM/rhBMP-2 in humans in 2014, while allogenic DDM/rhBMP-2 was successfully applied 
for upper right alveolar bone repair in 2016 [22].
Jeon et al. reported the evaluation of soft tissue volume change after socket preservation using 
DDM/rhBMP-2 compared with Bio-Oss collagen (Geistlich, Wolhusen, Switzerland) that the 
volume decreases of DDM/rhBMP-2 is not inferior to Bio-Oss [23].
Another clinical study of a total of 23 patients who received DDM/rhBMP-2 with implant 
placements (36 implants; maxilla: 14, mandible: 22) showed favorable osseointegration in 
terms of the implant stability, marginal bone loss, and clinical outcomes [24].
Recently, the author reported a clinical study of DDM/rhBMP-2 application on extraction 
socket preservation that DDM may be potential carrier of rhBMP-2 with reduced concentra-
tion of rhBMP-2 [25]. This chapter will introduce the surgical technique, clinical outcome, 
long term results of DDM/rhBMP-2 graft in implant dentistry.
2. Case reports
2.1. Preparation of DDM/rhBMP-2
DDM powder was produced using human teeth that were soaked in 70% ethyl alcohol. After 
dividing the teeth into the crown and root, the root portion was crushed to a powder. The size 
of the particles was between 300 and 800 μm diameter. The crushed particles were soaked 
in distilled water and a hydrogen dioxide solution, and the remaining foreign substances 
were removed by using an ultrasonic cleaner. The cleaned particles were dehydrated with 
ethyl alcohol and went through defatting using ethyl ether solutions. The particles were then 
demineralized for 30 min in 0.6 N HCl. The demineralized particles were lyophilized and 
sterilized with ethylene oxide gas (Figure 1a).
DDM block also was fabricated after crowns were severed at the cementoenamel junc-
tions. Only root dentin part was processed for the block fabrication (European Patent No. 
2462899) for its intended use as described in other report. [11] Additional holes sized in 
0.2–0.3 mm were made from surface of the root to the canal area to create through and 
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through macropores for promoting vascular invasion and bone formation. The block went 
through the same fabrication process with the powder form, but the only difference was 
not being crushed into particles so that the block maintains the original tooth root form and 
shape (Figure 1b).
DDM block can be transformed into various shapes according to its indication such as sheet 
like structure to be membrane substitute, ring structure for vertical augmentation (Figure 1c). 
Figure 1d shows the characteristic wettability with patient’s own blood via macropores of 
DDM block (Figure 1d).
The rhBMP-2 was loaded on the DDM powder and block by placing 5.0 μg of 0.2 mg/mL 
rhBMP-2 (Cowellmedi, Busan, Korea) and 0.3 g of DDM powder into individual 15-mL 
conical tubes. The mixtures were frozen in a deep freeze at −70°C for 60 min, slotted into a 
lyophilization glass bottle, and then fixed in a lyophilizer (ILShin Lab, Seoul, Korea). After 
sterilization with ethylene oxide, the DDM powder loaded with rhBMP-2 was packed and 
transported to the hospital where the implant surgery would be performed [22].
Because DDM/rhBMP-2 powder and block were manufactured in laboratory with maintain-
ing its form and shape clinician can use this material simple and easy as usual.
Demographic information of patients, sites, procedure, materials and follow-up periods are 
summarized in Table 1.
Figure 1. Types of DDM. (a) DDM powder; (b) DDM block with the through and through holes, 200–300μm diameter; 
(c) sheet like structure fabricated from block; (d) wettability with the blood via macropores.
Table 1. Demography of DDM/rhBMP-2 application.
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2.2. DDM/rhBMP-2 powder
2.2.1. Case 1: socket preservation on lower left first molar extraction site with simultaneous 
implant placement
Implants were placed on the extraction socket of the lower left first molar (Figure 2) together 
with DDM/rhBMP-2 powder to prevent buccal wall resorption otherwise buccal wall collapse 
could hinder the dental implant management (Figure 2a). During the secondary surgery, 4 
months post-implantation, sound bone and well organized tissues around the dental implant 
can be seen. DDM/rhBMP-2 powder seemed to be well incorporated with the extraction 
socket wall because both the border between the defect and DDM/rhBMP-2 particles was no 
longer visible (Figure 2b).
2.2.2. Case 2: socket preservation on upper right first molar with simultaneous implant 
placement
Implants was placed on the extraction socket of the upper right first molar (Figure 3) together 
with DDM/rhBMP-2 powder to prevent anticipated buccal wall resorption (Figure 3a). A cone 
beam computerized tomography (CBCT, Vatech, Seoul, Korea) image of the upper right first 
molar, taken three months after first surgery showed the graft which patched up the thin 
buccal cortical bone (Figure 3b). Six months post-implantation, i.e., at the time of secondary 
surgery, the buccal cortical bone seems to be resorbed and replaced with newly formed bone 
with the volume of socket wall maintained (Figure 3c). Three year seven months later with 
final prosthesis, the alveolar housing, surrounded dental implant, maintain its volume and 
shape as natural alveolar bone (Figure 3d).
Comparing 3D reconstructive images of immediate post operation to 3 year 7 months later 
indicated that the thin buccal cortical bone which was expected to be resorbed due to slightly 
Figure 2. Socket preservation on lower left first molar without covering membrane. (a). Dental implant was placed in the 
extraction socket with primary stability, and the gap between the implant and socket wall was filled with DDM/rhBMP-2 
powder without membrane. (b) Four months later, well organized bone was seen that surround the dental implant and 
repair all the gaps. Remnants of DDM/rhBMP-2 particles can not be seen.
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demineralized appearance (Figure 4a), and the alveolar bone surround the dental implant 
neck have been completely remodeled into a mature cortical bone which was fully supported 
by cancellous bone and marrow (Figure 4b).
2.2.3. Case 3: GBR on upper right central incisor
Upper right central incisor was extracted due to intermittent pain, swelling, and mobility 
for the past three years. One week after extraction, the implant (diameter: 3.8 mm, length: 13 
mm; Dio, Busan, Korea) was placed and the DDM/rhBMP-2 was grafted simultaneously with 
securing excellent primary stability (Figure 5a).
The labial defect and exposed implant were covered with DDM/rhBMP-2 powders (Figure 5b). 
The muco-periosteal flap was replaced and stabilized without a covering membrane. After 
one and half months, the patient underwent secondary surgery earlier than the conventional 
waiting period of 6 months due to her inevitable schedule. Newly formed bone was cov-
ered the labial defect and exposed implant completely. The volume was maintained and the 
remained particles were no longer seen (Figure 5c).
A CBCT image taken before and immediately after the primary surgery showed the missing 
part of the labial cortex and exposed implant that had been patched up by the DDM/rhBMP-2 
powder (Figure 6a and b). There were clear border lines separating the graft from the remain-
ing labial cortex (Figure 6b). After 3 years with final prosthesis, the labial defect appeared 
completely repaired by sound cortico-cancellous bone. The border at the upper labial defect 
had completely disappeared, indicating good incorporation of the graft into the alveolar bone 
as well as remodeling capacity into sound cortico-cancellous bone complex around implant 
neck (Figure 6c).
Figure 3. CBCT of socket preservation on upper right first molar with simultaneous implant placement. (a) Immediate 
postoperative image showed gap between the implant and thin buccal cortical bone which is expected to be resorbed. 
(b) Three months after graft, thinning buccal cortical bone indicated the beginning of remodeling. (c) Six months after 
graft, buccal cortical bone was almost disappeared with the volume of extraction socket maintained. (d) Three year 7 
months after, alveolar bone around the dental implant turned into a mature cortical-cancellous bone complex (arrow = 
alveolar bone).
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2.2.4. Case 4: ridge split and expansion on lower central incisors
Ridge split procedure was performed to secure the labio-lingual dimension for implant place-
ment (diameter: 3.8 mm, length: 13 mm; Daemul, Seoul, Korea) on lower central incisors 
(Figure 7a). The gaps created by ridge split and implant placement were filled with DDM/
rhBMP-2 powders (Figure 7b). Two and a half months later, the whole DDM/rhBMp-2 par-
ticles have changed into well-organized bone-like structure with remarkably increased ridge 
width and height (Figure 7c). Well organized tissues covered screw was retrieved for histo-
logical examination (Figure 7d). There were no inflammatory cells or foreign body reactions 
and were no gaps between the DDM particle and the newly formed bone (Figure 7e).
Figure 4. 3D reconstructive image from CBCT. (a) The demineralized buccal cortical bone which was expected to be 
resorbed. (b) The alveolar bone surround the implant neck have been completely remodeled into a mature cortico-
cancellous bone complex.
Figure 5. GBR on upper right central incisor. (a) Exposed dental implant and labial defect immediate after implant 
placement. (b) Exposed defect were covered with DDM/rhBMP-2 powders. See the wettability of DDM with blood that 
provides immobility to the powders without membrane. (c) Six weeks after, well organized, newly formed bones filled 
the labial defect and surround the dental implant.
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Histologic specimens of DDM alone at this area have shown that the particle was surrounded 
by a dense fibrotic capsule consisting of 3–4 cell layers where there are no inflammatory cells or 
foreign body reactions as the evidences of biocompatibility of DDM due to the environmental 
Figure 7. DDM/rhBMP-2 powder application on lower central incisors. (a) Implant placement after ridge split 
procedure. (b) The space between the implants and labial cortical plate is filled with DDM/rhBMP-2. No membrane 
is used. (c) Two and a half months later, a well-organized bone-like structure surrounded implant. The ridge width 
increased remarkably. (d) Uncovering implant. Tissue over the implant is used for histological evaluation. (e) Histologic 
specimen shows active new bone formation around DDM particle. Void space is the DDM which was detached during 
histologic processing. (Hematoxylin and eosin staining, Scale bar = 5.0 μm). From Um et al. [22] (Figure 3).
Figure 6. CBCT images of GBR on upper right central incisor. (a) Before extraction of upper right central incisor; (b) 
placement of dental implant and GBR was done for labial defect; (c) Three years follow up. The cortico-cancellous bone 
complex was recovered completely (arrow = alveolar bone).
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factors of poor blood supply in between the cover screw and the gingiva, we could not find 
the bone formation at this area before. [22] However, DDM/rhBMP-2 specimen in this case 
showed remarkable amount of bone formation around DDM/rhBMP-2 particles (Figure 7e). 
This may be explained by the positive effect of additional rhBMP-2 on DDM.
A CBCT image taken seven months after surgery showed a completely repaired labial bone. 
The demarcated border between the remaining labial cortex and the repaired bone has almost 
disappeared (Figure 8a and b). After 3 years with final prosthesis, the labial cortex becomes 
more thickened and fully supported by cancellous bone and marrow (Figure 8c).
2.2.5. Case 5: alveolar bone augmentation on lower left canine
Extraction of canine, which were sent to Korea Tooth Bank for fabrication of DDM/rhBMP-2, 
were performed one week before implant placement. Full thickness flaps were elevated to 
expose the alveolar crest and locate the defective area. Cleaning and removal of the granula-
tion tissues revealed a huge, crater-like defect with complete destruction of the labial wall 
(Figure 9a). The implant (diameter: 3.8 mm, length: 13 mm; Dio, Busan, Korea) was placed 
and an excellent primary stability was obtained (Figure 9b). The huge defect and exposed 
implant were filled and augmented with DDM/rhBMP-2 that was prepared for easy mold-
ing and shaping (Figure 9c). The DDM/rhBMP-2 was placed and carefully packed into the 
destroyed area of the lingual wall and extended to the surface of the lateral buccal wall, with-
out applying excessive pressure. The mucoperiosteal flap was replaced without a covering 
membrane (Figure 9d).
When the patient underwent secondary surgery, six months later, well-formed bone, which 
surrounds the implant and fill the gap, can be seen (Figure 9e). All routine prosthetic proce-
dures after removal of bone over cover screw were performed (Figure 9f).
A CBCT image taken immediately after surgery showed that the missing part of the labial 
cortex had been patched up by the DDM/rhBMP-2 powder. There was clear border line 
Figure 8. Cone beam computerized tomography (CBCT) of DDM/rhBMP-2 application on lower central incisor. 
(a) Immediately after implant placement and DDM/rhBMP-2 graft. There is obvious lower labial defect. (b) After 
7 months. Labial cortical bone is completely repaired and the demarcated defect border has almost disappeared. 
(c) After 3 years. The labial cortex becomes thicker and shows fully developed cortico-cancellous bone complex 
(arrow = alveolar bone). From Um et al. [22] (Figure 4).
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Figure 10. Cone beam computerized tomography (CBCT) of lower left canine repaired by DDM/rhBMP-2. (a) Immediately 
after implant placement and graft. DDM/rhBMP-2 particles surround the implant, patching up the labial and crestal 
alveolar bone. (b) After 3 years, the border line at the lower labial defect has completely disappeared. The repaired labial 
cortical bone was fully supported by cancellous bone and marrow (arrow = alveolar bone). From Um et al. [22] (Figure 2).
Figure 9. DDM/rhBMP-2 application on lower left canine. (a). There was huge defect after removal of all granulations 
on lower left canine. (b). Placement of implant (diameter: 3.8 mm, length: 13 mm) ensuring initial stability. (c). DDM/
rhBMP-2 particles can be molded and shaped easily. (d). DDM/rhBMP-2 is packed into the lingual wall gap and along 
the labial wall. No membrane is used. (e). Well-organized bone tissue was found, filling the gap and surround the 
implant completely. None of the particles can be seen. (f). The tissue over the cover screw is typically removed in order 
to go through the prosthetic procedure and histological evaluation. From Um et al. [22] (Figure 1).
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separating the graft from the remaining labial cortex (Figure 10a). After three years with final 
prosthesis, the alveolar bone was repaired completely in both volume and shape. The border 
at the lower labial defect had completely disappeared, indicating good incorporation of the 
graft into the alveolar bone. The repaired labial cortical bone seemed to be fully supported by 
cancellous bone and marrow (Figure 10b).
2.3. DDM/rhBMP-2 block
2.3.1. Case 1: GBR for the repair of alveolar wall on lower left first molar
After extraction of lower left first molar, there was collapsed buccal wall resulting in huge, 
crater-like defect (Figure 11a and b). Using the extracted tooth, block and powder type DDM/
rhBMP-2 were prepared (Figure 11c). Buccal wall was repaired by block and the alveolar 
proper was repaired by powder (Figure 11d). Six months later for the staged procedure of 
implant placement, there was a bone-like tissue that was completely transformed from the 
block and powder of DDM/rhBMP-2. Alveolar bone seemed to be repaired completely with-
out any remnants of block and powder (Figure 11e). So that the implant can be secured safely 
on the repaired alveolar bone (Figure 11f).
A CBCT image taken before and after extraction showed complete loss of buccal wall 
(Figure 12a and b). The alveolar proper was repaired by DDM/rhBMP-2 powder while the 
missing part of buccal wall was repaired by DDM/rhBMP-2 block. There was clear border 
line separating the block graft from the remaining buccal cortical bone (Figure 12c). After 6 
months, the border line began to disappear that indicate good incorporation and remodeling 
Figure 11. GBR for the repair of alveolar wall on lower left first molar. (a) Collapsed buccal wall after extraction of lower 
left first molar. (b) Reflection of flap and removal of granulation tissues. Huge defect and resorbed buccal wall can be 
seen. (c) Fabricated DDM/rhBMP-2 block from extracted tooth. (d) The huge defect was repaired by DDM/rhBMP-2 block 
and powder. (e) Six months later, whole DDM/rhBMP-2 was completely transformed into bone like structure. (f) Implant 
placement (staged procedure).
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(Figure 12d), and 12 months later, radiopaque outer cortex and remodeled powder can be 
seen (Figure 12e). The alveolar bone surround the implant appeared completely repaired in 
both volume and shape.
2.3.2. Case 2: onlay graft on upper right first molar for volume expansion
After placement of implant, there was an atrophy of buccal cortical area (Figure 13a). DDM/
rhBMP-2 block and powder was put on the buccal resorbed area that showed sound wettability 
with patients own blood and immobilization. The color change of the DDM/rhBMP-2 is mainly 
due to soaking with the patient’s own blood into the macropores and collagenous dentin matrix 
(Figure 13b). Flap was closed without using membrane. The flap reflected again for the prosthetic 
procedure 4 months later, there were no discernible block and powders remained and well orga-
nized tissues replaced the onlay graft with the volume and shape maintained (Figure 13c and d).
Figure 13. Onlay graft on upper right first molar for volume expansion. (a) Atrophied buccal area can be seen after 
placement of implant. (b) DDM/rhBMP-2 block and powder were put on the buccal resorbed area. No membrane was 
used due to the wettability of block and power with patient’s own blood resulting in immobilization. (c) Four months 
later, there were no DDM particles and block that have changed into well-organized tissues maintaining the whole 
volume of DDM/rhBMP-2. (d) See the increased volume of buccal gingiva and texture.
Figure 12. GBR for the repair of alveolar wall on lower left first molar. (a) Before extraction. (b) Immediate after extraction. 
Complete loss of buccal wall can be seen. (c) Repair the alveolar proper with DDM/rhBMP-2 powder and the buccal wall 
with DDM/rhBMP-2 block. (d) Six months later, placement of implant. See the remodeled powder. (e) Seven months 
after. Powders are remodeled in the alveolar proper, while the block repaired buccal cortical bone (arrow = alveolar 
bone).
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CBCT images after implant placement on upper right first molar. As a result of long term 
missing of tooth, alveolar ridge became narrow and the buccal cortical bone around the dental 
implant is too thin and close to implant neck (Figure 14a). Increased alveolar bone width and 
volume by DDM/rhBMP-2 application can be seen (Figure 14b). Seven years later, increased 
volume of alveolar housing, remodeled completely, shows mature cortico-cancellous bone 
complex (Figure 14c).
3. Discussion
Unlike other scaffolds, for example, ACS which has a limited capacity for controlled release, 
lacks of structural stability, risk of physiologically excessive doses, and the insufficient reten-
tion of BMP-2 [14–16], DDM has adequate porosity to allow cell and blood vessel infiltration, 
appropriate mechanical stability to withstand compression and tension, biocompatibility, bio-
degradability, amenability to sterilization, adhesiveness to adjacent bone, affinity for BMPs, 
and the ability to retain the protein for a sufficient period [17, 26]. DDM has a microporous 
structure with dentinal tubules 3–5 μm in diameter, which allows it not only to contain BMPs, 
but also to efficiently release them at surgical site [20]. Numerous studies have reported on the 
performance of DDM as a scaffold for BMPs; the osteoconductive and osteoinductive abilities 
of DDM are deemed to be its greatest strengths [18–20].
3.1. Experimental studies of DDM/rhMP-2
As a candidate for an rhBMP-2 carrier, Ike et al. reported that xenogenous rhBMP-2 adsorbed into 
pulverized root and partially DDM proved to be as osteoinductive as an autogenous bone graft 
[18]. Murata also showed that human DDM particles are osteoinductive, insoluble collagenous 
matrices, and that DDMs might be effective as an rhBMP-2 carrier for bone engineering [19].
Figure 14. CBCT images of onlay graft on upper right first molar. (a) After placement of 3.8 mm diameter implant, the 
buccal cortical bone around the dental implant is too thin and close to implant neck. (b) Increased alveolar bone volume 
around implant neck area by DDM/rhBMP-2 application can be seen. (c) Seven years later, onlay DDM/rhBMP-2 was 
well incorporated with the buccal cortical bone under continuous remodeling, that create new cortico-cancellous bone 
complex (arrow = alveolar bone).
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The first report of human DDM/rhBMP-2 have demonstrated that DDM displays the highest 
released to loaded rhBMP-2 ratio, the lowest release speed, and the highest induction of osteo-
nectin expression, resulting in augmented mature bone formation compare with tricalcium 
phosphate (TCP) [12]. Um et al. examined the bone induction capacity of DDM/ rhBMP-2 
compare with conventional TCP in the muscle pouches of nude mice. The results were that 
the early cellular reaction on the surface of particles was superior in the DDM/ rhBMP-2 
group, more osteoid was deposited on the DDM/ rhBMP-2 group [25].
In the rabbit’s calvarial defect, the DDM and anorganic bovine bone combined with 
rhBMP-2 (ABB/rhBMP-2) groups showed osteoconductive bone formation, while the 
DDM/rhBMP-2 group showed osteoconductive and osteoinductive bone formation. The 
DDM/rhBMP-2 group showed a twofold greater amount of bone formation compared to 
the DDM alone and ABB/rhBMP-2 groups. The μCT analysis showed markedly increased 
bone volume in the DDM/rhBMP-2 group at eight weeks compared with that of the DDM 
group [21]. Kim et al. evaluated the efficacy of DDM/rhBMP-2 in the unilateral upper sec-
ond and third premolars of eight beagles compare with the autogenous bone and reported 
equality of DDM/rhBMP-2 to autogenous bone [24].
3.2. Clinical studies of DDM/ rhBMP-2
Case series study of comparing short term outcome of DDM/rhBMP-2 (Bioα, Seongnam, 
Korea) with hydroxyapatite (HA)/rhBMP-2 (Bioα, Seongnam, Korea), reported that rhBMP-2 
combined with HA or DDM scaffolds can be used for bone graft procedures such as guided 
bone regeneration [20].
About the effectiveness of DDM/rhBMP-2 (CowellMedi, Busan, Korea) for alveolar bone 
repair [27, 28], the clinical findings with respect to the healing process were that there were 
no remarkable inflammation and immune rejection that impair the healing process and 
are coincident with those of the previous studies of DDM alone [8, 10, 29]. The nanopore 
structure of dentinal tubules in unique avascular and acellular Type I collagenous dentin 
matrix seems to make it feasible to carry and release rhBMP-2 effectively on local site based 
on the previous study [30, 31].
In the clinical study of histological comparison of autogenous and allogenic DDM/rhBMP-2 
at the site between the implant cover screw and gingiva, as the poor blood supply allows it to 
simulate a heterotopic condition, three patients undergoing simultaneous implant placement 
and receiving a different type of graft were included: allogenic DDM loaded with rhBMP-2 
(DDM/rhBMP-2), autogenous DDM/rhBMP-2 and autogenous DDM. After 3–6 months of 
grafts, the antigenicity and immunogenicity of the carrier allogenic DDMs are low enough to 
maintain both the biocompatibility of the scaffold and the activity of the loaded rhBMP-2 [22].
Jeon et al. reported study to evaluate soft tissue volume change after socket preservation 
using DDM alone, DDM/rhBMP-2 and Bio-Oss collagen (Geistlich, Wolhusen, Switzerland). 
According to soft tissue volume changes, each groups showed statistically meaningful vol-
ume decreases. Bio-Oss collagen showed 15.4% volume decrease, DDM showed 18.8% and 
DDM/rhBMP-2 showed 16.1% decrease, respectively. However, there were no significant dif-
ferences among groups [23].
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In the clinical study of a total of 23 patients who received bone grafts using human DDM/
rhBMP-2 with implant placements (36 implants; maxilla: 14, mandible: 22). The implant sta-
bility, marginal bone loss, and clinical outcome were evaluated. Favorable osseointegration 
was obtained in 35 out of 36 implant sites (one case of osseointegration failure) and severe 
complications were not observed in all cases [24].
3.3. Case report of DDM/ rhBMP-2
Each case report represent socket preservation, GBR, ridge split and expansion, onlay graft 
with simultaneous or staged implant placement. Besides the crucial factors for implant success 
such as stability, peri-implantitis, the first critical observation in this case presentation is the 
texture of tissues formed around the implant at second surgery time without using any mem-
branes. The powder or block that were no longer visible when the flap reflected at 3–6 months 
after graft indicated good incorporation and remodeling capacities of DDM into host bed. 
These phenomena might be explained by the synergistic effect of exogenous rhBMP-2 with 
endogenous growth factors in DDM that is both increased bone formation and accelerated 
DDM degradation. This is assumption raised and explained in the previous report [18, 19, 31].
Second observation is the structure of bone around the implant neck area where the major 
peri-implantitis start and accumulated. What we need for ideal osseointegration is sound 
alveolar bone with appropriate volume and shape at this defense front area. The sound alveo-
lar bone consist of cortical bone with enough thickness, and cancellous bone with mature bone 
marrow that is inevitable for continuous remodeling with standing for occlusal forces. At least 
one year after final prosthesis, we found sound cortical bone supported by fully developed 
cancellous bone in CBCT analysis. And the time to achieve sound bone around the neck area 
might be faster than that of DDM alone [8].
Third observation is histologic evidences we presented recently that shows more bone forma-
tion at each time point and accelerated resorption of DDM compare to other carriers such as 
HA and TCP [25].
Finally, the rationale for not using membrane is that carrier DDM is a collagenous scaffold 
with minerals to be able to absorb enough blood resulting in space maintenance and invasion 
of blood vessels from the host. In the clinical study of DDM/rhBMP-2 application in on extrac-
tion socket preservation, there were no cellular invasion from gum tissues to hinder bone 
formation clinically and radiologically [25].
4. Conclusion
The clinical application of DDM/ rhBMP-2 showed successful alveolar socket preservation, GBR, 
onlay graft in implant dentistry without any complications. Furthermore, this clinical success 
may open the way to new technology for alveolar bone repair, even though the cases presented 
here are small numbers and not representative to conclude the clinical superiority compare to 
others. For example, because the long term data of DDM/rhBMP-2 in sinus augmentation are 
not established yet, we need to collect more data from well controlled prospective studies.
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Based on several other reports that have shown favorable results from using DDM/rhBMP-2 in 
implant dentistry, we are going to perform more number of clinical studies such as prospec-
tive, randomized, controlled clinical trials for the purpose of assuring the safety and efficacy 
of DDM as a promising carrier for rhBMP-2.
By the application of rhBMP-2 from experimental researches to clinical reality, the num-
ber of choice of alternative bone graft substitutes has been increased in implant dentistry. 
Although significant effort has been made to find a safer, cheaper, and more efficient scaffold 
for rhBMP-2 carrier, there have not been sufficient studies and efforts that focused on the 
application of rhBMP-2 in dental field.
By the discovery and successful applications of DDM as rhBMP-2 carrier in implant dentistry, 
we might have cheaper, safer and more efficient bone graft substitute. Reduced concentration 
of rhBMP-2 with similar or superior efficacy in inducing bone formation without the adverse 
effects made the DDM/rhBMP-2 revolutionary cost-effective and safe that eliminates most of 
the side effects associated with supraphysiologic overdose concentration.
Up to date, the long term results of DDM/rhBMp-2 are clearly promising in biologic activities 
and cost-benefits for the patients that would open the door to develop DDM as carrier of stem 
cells to be applied in implant dentistry.
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